Download in PDF Format
Highlights:
Novavax Announces New Capital Infusion through a Strategic Alliance with Cadila Pharmaceuticals of India
Joint Venture to be funded by Cadila Pharmaceuticals and Revenues from Sales of Biogenerics; Deal Includes $11 Million Capital Investment in Novavax